A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata

PHASE3CompletedINTERVENTIONAL
Enrollment

546

Participants

Timeline

Start Date

July 8, 2019

Primary Completion Date

January 24, 2021

Study Completion Date

November 19, 2024

Conditions
Alopecia Areata
Interventions
DRUG

Baricitinib

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (96)

333

Chang Gung Medical Foundation-Linkou Branch, Taoyuan District

402

Chung Shan Medical University Hospital, Taichung

704

National Cheng Kung University Hospital, Tainan City

1027

Centro de Investigaciones Metabólicas (CINME), Ciudad Autónoma de Buenos Aires

1055

Buenos Aires Skin, Buenos Aires

1425

Instituto de Neumonología y Dermatología, Capital Federal

2045

Skin & Cancer Foundation Australia, Westmead

2606

Woden Dermatology, Phillip

3002

Sinclair Dermatology, Melbourne

3053

Skin Health Institute Inc., Carlton

4102

Veracity Clinical Research Pty Ltd, Woolloongabba

5073

Clinical Trials SA Pty Ltd, Campbelltown

5500

Parra Dermatología, Mendoza

6160

Fremantle Dermatology, Fremantle

10002

National Taiwan University Hospital, Taipei

12180

Joseph J. Schwartz, M.D., Troy

14584

Soonchunhyang University Bucheon Hospital, Bucheon-si

16499

Ajou University Hospital, Suwon

20850

Dermatology and Skin Cancer Specialists, Rockville

23502

Virginia Clinical Research, Inc., Norfolk

27516

The University of North Carolina at Chapel Hill, Chapel Hill

27612

M3-Emerging Medical Research, Raleigh

28211

Dermatology Specialists of Charlotte, Charlotte

30001

First Affiliated Hospital of Shanxi Medical University, Taiyuan

31116

Dankook University Hospital, Cheonan

33134

Florida Academic Centers Research and Education, LLC, Coral Gables

33165

New Horizon Research Center, Miami

35205

Total Skin and Beauty Dermatology Center, PC, Birmingham

42303

Qualmedica Research, LLC, Owensboro

43209

Bexley Dermatology Research, Bexley

44106

University Hospitals Cleveland Medical Center, Cleveland

45040

Dermatologists of Southwest Ohio, Mason

46250

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

46617

The South Bend Clinic Center for Research, South Bend

48047

Clinical Research Institute of Michigan, LLC, Chesterfield

48059

Hamzavi Dermatology, Fort Gratiot

48706

Great Lakes Research Group, Inc., Bay City

55112

Associated Skin Care Specialists, New Brighton

64506

MediSearch Clinical Trials, Saint Joseph

74136

Vital Prospects Clinical Research Institute, P.C., Tulsa

77056

Suzanne Bruce and Associates, PA, Houston

78213

Progressive Clinical Research, San Antonio

85255

Investigate MD, Scottsdale

91324

Quest Dermatology Research, Northridge

94118

Kaiser Permanente Hospital, San Francisco

94538

Center For Dermatology Clinical Research, Inc., Fremont

97210

Northwest Dermatology Institute, Portland

Oregon Dermatology and Research Center, Portland

100020

Beijing Chao-Yang Hospital, Capital Medical University, Beijing

100050

Beijing Friendship Hospital Affiliate of Capital University, Beijing

100191

Peking University Third Hospital, Beijing

100853

Chinese PLA General Hospital, Beijing

200040

HuaShan Hospital Affiliated To Fudan University, Shanghai

200071

Shanghai Skin Disease Hospital, Shanghai

210029

Jiangsu Province Hospital, Nanjing

212000

Affiliated Hospital of Jiangsu University, Zhenjiang

300052

Tianjin Medical University General Hospital, Tianjin

310014

Zhejiang Provincial People's Hospital, Hangzhou

310052

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

410008

Xiangya Hospital Central South University, Changsha

510018

Guangdong Province Dermatology Hospital, Guangzhou

710004

The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an

1834111

Emek Medical Center, Afula

3109601

Rambam Medical Center, Haifa

4941492

Rabin Medical Center, Petah Tikva

5262100

Sheba Medical Center, Ramat Gan

6423906

Sourasky Medical Center, Tel Aviv

8410101

Soroka Medical Center, Beersheba

9112001

Hadassah Medical Center, Jerusalem

06606

New England Research Associates, Bridgeport

33613-1244

ForCare Clinical Research, Tampa

02111

Tufts Medical Center, Boston

02818

Velocity Clinical Research, Providence, East Greenwich

C1023AAB

Stat Research, CABA

C1426ABO

Fundacion Respirar, Buenos Aires

T4000AXL

Centro de Investigaciones Médicas Tucuman, SAN M. de Tucuman

22470-220

IDERJ - Instituto de Dermatologia e Estética do Brasil, Rio de Janeiro

90050-170

Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre

13034-685

Centro de Pesquisa Sao Lucas, Campinas

13083-888

Hospital de Clínicas Da Universidade Estadual de Campinas, Campinas

09060-870

Faculdade de Medicina do ABC, Santo André

22241-180

IBPClin - Instituto Brasil de Pesquisa Clínica, Rio de Janeiro

01223-001

IPITEC, São Paulo

04039-901

Servidor Público Estadual - IAMSPE - centro de estudos urológicos, São Paulo

222-0036

Yokohama Rosai Hospital, Yokohama

431-3192

Hamamatsu University Hospital, Hamamatsu

113-8431

Juntendo University Hospital, Bunkyo-ku

136-0075

Juntendo Tokyo Koto Geriatric Medical Center, Koto-ku

181-8611

Kyorin University Hospital, Mitaka

160-0023

Tokyo Medical Univ. Hospital, Shinjuku-ku

755-8505

Yamaguchi University Hospital, Ube

545-8586

Osaka City University Hospital, Osaka

00909

Clinical Research Puerto Rico, San Juan

07061

Boramae Medical Center, Dongjak-gu

134-090

Kyunghee University Hospital at Gangdong, Seoul

03722

Severance Hospital, Yonsei University Health System, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Incyte Corporation

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT03899259 - A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata | Biotech Hunter | Biotech Hunter